Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipophilic toxicants represent a broad class of hydrophobic chemical substances, including persistent organic pollutants (POPs) such as dioxins, polychlorinated biphenyls (PCBs), and organochlorine pesticides, that preferentially accumulate in the adipose tissue of living organisms (NIH/PubMed, PMID: 24075211). These substances are characterized by high lipid solubility and significant resistance to environmental and metabolic degradation, allowing them to persist in the human body for years or even decades (WHO, 2010). Their presence is linked to a variety of adverse health outcomes, including endocrine disruption, developmental neurotoxicity, and increased cancer risk, primarily through their interaction with intracellular receptors like the Aryl hydrocarbon receptor (AhR) or through the induction of oxidative stress (PubMed, PMID: 28245917). While not a 'therapeutic target' in the traditional sense of a specific protein or enzyme, they are the focus of clinical detoxification strategies that utilize sequestering agents such as non-absorbable lipids or intravenous lipid emulsions to accelerate their clearance and prevent reabsorption (StatPearls, NBK549767). A major clinical challenge involves the mobilization of these toxicants from fat stores into the systemic circulation during periods of rapid weight loss or physiological stress, which can lead to acute symptomatic toxicity (PubMed, PMID: 21062098).
Sequestration and enhancement of fecal excretion via the interruption of enterohepatic circulation or the creation of a systemic lipid sink to redistribute toxins away from target organs.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipophilic toxicants.